Journal of Reproductive Immunology
Volume 83, Issue 1 , Pages 158-163 , December 2009

Gonadotropin-releasing hormone/human chorionic gonadotropin β based recombinant antibodies and vaccines

Received 13 December 2008 ,Revised 10 August 2009 ,Accepted 25 August 2009.

References 

  1. Crawford RA, Iles RK, Carter PG, Caldwell CJ, Shepherd JH, Chard T. The prognostic significance of beta human chorionic gonadotropin and its metabolites in women with cervical carcinoma. J. Clin. Pathol. 1998;51:685–688
  2. De Bruijn HW, ten Hoor KA, Krans M, van der Zee AG. Rising serum values of beta-subunit human chorionic gonadotropin (hCG) in patients with progressive vulvar carcinomas. Br. J. Cancer. 1997;75:1217–1218
  3. Diwan M, Dawar H, Talwar GP. Induction of early and bioeffective antibody response in rodents with the anti LHRH vaccine given as a single dose in biodegradable microspheres along with alum. Prostate. 1998;35:279–284
  4. Fishel SB, Edwards RG, Evans CJ. Human chorionic gonadotropin secreted by pre-implantation embryos cultured in vitro. Science. 1984;223:816–818
  5. Furest J, Fiebiger E, Jungwirth A, Mack D, Talwar GP, Frick J, et al. Effect of active immunization against luteinizing hormone-releasing hormone on the androgen-sensitive Dunning R3327-PAP and androgen independent Dunning R3327-AT2.1 prostate cancer sublines. Prostate. 1997;32:77–84
  6. Gaur A, Arunan K, Singh O, Talwar GP. Bypass by an alternate carrier of acquired unresponsiveness to hCG upon repeated immunization with tetanus conjugated vaccine. Int. Immunol. 1990;2:151–155
  7. Giri DK, Jayaraman S, Neelaram GS, Jayashankar R, Talwar GP. Prostatic hypoplasia in Bonnet monkeys following active immunization with semi-synthetic anti-LHRH vaccine. Exp. Mol. Pathol. 1991;54:255–264
  8. Gupta JC, Raina K, Talwar GP, Verma R, Khanna N. Engineering, cloning and expression of genes encoding the multimeric luteinising-hormone-releasing-hormone linked to T-cell determinants in Escherichia coli. Protein Express. Purif. 2004;37:1–7
  9. Hearn JP, Gidley-Baird AA, Hodges JK, Summers PM, Webley GE. Embryonic signals during the pre-implantation period in primates. J. Reprod. Fertil. Suppl. 1988;36:49–58
  10. Hotakainen K, Ljungberg B, Paju A, Rasmuson T, Alfthan H, Stenman UH. The free beta-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma. Br. J. Cancer. 2002;86:185–189
  11. Iles RK. Ectopic hCGβ expression by epithelial cancer: malignant behaviour, metastasis and inhibition of tumor cell apoptosis. Mol. Cell. Endocrinol. 2007;260–262:264–270
  12. Iles RK, Persad R, Trivedi M, Sharma KB, Dickinson A, Smith P. Urinary concentration of human chorionic gonadotropin and its fragments as a prognostic marker in bladder cancer. Br. J. Urol. 1996;77:61–69
  13. Jayashankar R, Chaudhari M, Singh OM, Alam A, Talwar GP. Semisynthetic anti-LHRH vaccine causing atrophy of the prostate. Prostate. 1989;14:3–11
  14. Kharat I, Nair NS, Dhall K, Sawhney H, Krishna O, Shahani SM, et al. Analysis of menstrual records of women immunized with anti-hCG vaccine inducing antibodies partly cross-reactive with hLH. Contraception. 1990;41:293–299
  15. Lundin M, Nordling S, Carpelan-Holmstrom M, Louhimo J, Alfthan H, Stenman UH. A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer. Anticancer Res. 2000;20:4949–4951
  16. Miller LA, Talwar GP, Killlian GJ. Contraceptive effect of a recombinant GnRH vaccine in adult female pigs. Proc. Vertebr. Pest Conf. 2006;22:106–109
  17. Nash H, Johanson ED, Talwar GP, Vasquez J, Seghal S, Coutinho E, et al. Observations on the antigenecity and clinical effects of a candidate anti-pregnancy vaccine: β subunit of human chorionic gonadotropin linked to tetanus toxoid. Fertil. Steril. 1980;34:328–335
  18. Parkinson RJ, Simms MS, Broome P, Humphreys JE, Bishop MC. A vaccination strategy for the long-term suppression of androgens in advanced prostate cancer. Eur. Urol. 2004;45:171–175
  19. Raina K, Panda AK, Ali MM, Talwar GP. Purification, refolding, and characterization of recombinant LHRH-T multimer. Protein Express. Purif. 2004;37:8–17
  20. Ramakrishnan S, Das C, Dubey SK, Salahuddin M, Talwar GP. Immunogenecity of three C-terminal synthetic peptides of the beta subunit of human chorionic gonadotropin and properties of the antibodies raised against 45- aminoacid C-terminal peptide. J. Reprod. Immunol. 1979;1:249–261
  21. Rau B, Below C, Liebrich W, von Schilling C, Schlag PM. Significance of serum hCGβ as a tumor marker for stomach carcinoma. Langenbecks Arch. Chir. 1995;380:359–364
  22. Rose NR, Burek CL, Smith JP. Safety evaluation of hCG vaccine in primates: auto-antibodies production. In:  Talwar GP editors. Contraception Research for Today and Nineties. New York: Springer-Verlag; 1988;p. 231–239
  23. Rovan E, Fiebiger E, Kalla NR, Talwar GP, Aulitzky W, Frick J. Effect of active immunization to luteinizing-hormone-releasing hormone on the fertility and histoarchitecture of the reproductive organs of male rat. Urol. Res. 1992;20:323–334
  24. Sahal D, Ramakrishnan S, Iyer KSN, Das C, Talwar GP. Immunobiological properties of a carboxy-terminal 53-amino acid peptide of the beta subunit of human chorionic gonadotropin. J. Reprod. Immunol. 1982;4:145–146
  25. Scholl PD, Jurco S, Austin JR. Ectopic production of beta-HCG by a maxillary squamous cell carcinoma. Head Neck. 1997;19:701–705
  26. Shastri N, Manhar SK, Talwar GP. Important role of the carrier in the induction of antibody response without Freund's complete adjuvant against a ‘self’ peptide hormone LHRH. Am. J. Reprod. Immunol. 1981;1:262–265
  27. Sheaff MT, Martin JE, Badenoch DF, Baithun SI. Beta hCG as a prognostic marker in adenocarcinoma of the prostate. J. Clin. Pathol. 1996;49:693–694
  28. Simms MS, Scholfield DP, Jacobs E, Michaeli D, Broome P, Humphreys JE, et al. Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer. Br. J. Cancer. 2000;83:443–446
  29. Singh M, Das SK, Suri S, Singh O, Talwar GP. Regain of fertility and normality of progeny born during below protective threshold antibody titers in women immunized with the HSD-hCG vaccine. Am. J. Reprod. Immunol. 1998;39:395–398
  30. Steven VC, Cinaver B, Powell JE, Lee SE, Koh SW. Preparation and formulation of a hCG antifertility vaccine. Selection of adjuvant and vehicle. Am. J. Reprod. Immunol. Microbiol. 1981;6:315–321
  31. Syrigos KN, Fyssas I, Konstandoulakis MM, Harrington KJ, Papadopoulos S, Milingos N, et al. Beta human chorionic gonadotropin concentrations in serum of patients with pancreatic adenocarcinoma. Gut. 1998;42:88–91
  32. Szturmowicz M, Slodkowska J, Zych J, Rudzinski P, Sakowicz A, Rowinska- Zakrzewska E. Frequency and clinical significance of beta-subunit human chorionic gonadotropin expression in non- small cell lung cancer patients. Tumour Biol. 1999;20:99–104
  33. Talwar GP, Sharma NC, Dubey SK, Salahuddin M, Das C, Ramakrishnan S, et al. Isoimmunisation against human chorionic gonadotropin with conjugates of processed beta subunit of the hormone and tetanus toxoid. Proc. Natl. Acad.Sci. U.S.A. 1976;73:218–222
  34. Talwar GP, Hingorani V, Kumar S, Roy S, Banerjee AK, Shahini SM, et al. Phase I clinical trials with three formulations of anti-human chorionic gonadotropin vaccine. Contraception. 1990;41:301–316
  35. Talwar, G.P., Chaudhuri, M.K., Jayshankar, R., 1992. Inventors. Antigenic derivative of GnRH. UK Patent, 2228262.
  36. Talwar GP, Singh O, Pal R, Chatterjee N, Sahai P, Dhall K, et al. A vaccine that prevents pregnancy in women. Proc. Natl. Acad. Sci. U.S.A. 1994;91:8532–8536
  37. Talwar GP, Singh O, Gupta SK, Hasnain SE, Pal R, Majumdar SS, et al. The HSD-hCG vaccine prevents pregnancy in women, fesability studies of reversibily safe contraception vaccine. Am. J. Reprod. Immunol. 1997;37:153–160
  38. Talwar GP, Diwan M, Dawar H, Frick J, Sharma SK, Wadhwa SN. Counter GnRH vaccine. In:  Rajalakshmi M,  Griffin PD editor. Male Contraception Present and Future. New Delhi: New Age International; 1998;p. 309–318
  39. Talwar GP, Raina K, Gupta JC, Ray R, Wadhwa S, Ali MM. A recombinant luteinising-hormone-releasing-hormone immunogen bioeffective in causing prostatic atrophy. Vaccine. 2004;22:3713–3721
  40. Vyas HK, Pal R, Vishwakarma R, Lohiya NK, Talwar GP. Selective killing of leukemia and lymphoma cells expressing ectopically hCGβ by a conjugate of curcumin with an antibody against hCGβ subunit. Oncology. 2009;265:101–111

PII: S0165-0378(09)00453-7

doi: 10.1016/j.jri.2009.08.008

Journal of Reproductive Immunology
Volume 83, Issue 1 , Pages 158-163 , December 2009